Events

Recall of Insulin syringe

According to L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), this recall involved a device in France that was produced by CODAN France.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Date
    2003-09-17
  • Event Country
    France
  • Event Source
    ANSM
  • Event Source URL
    https://ansm.sante.fr/S-informer/Informations-de-securite-Retraits-de-lots-et-de-produits/retrait-de-lot-de-seringues-a-insuline-de-la-societe-codan
  • Notes / Alerts
    French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
  • Extra notes in the data
  • Action
    The company CODAN France withdraws from the market the 80832 batch of the reference 62.1663 named insulin syringe following the report of an incident namely the mixing of insulin syringes with tuberculin syringes in the same cardboard labeled "insulin syringes". The 15 customers concerned (hospitals and clinics) are notified directly by the manufacturer.

Device

Insulin syringe
  • Model / Serial
  • Product Description
    medical_device
  • Manufacturer
    CODAN France

Manufacturer

CODAN France
  • Source
    LAANSM